India has faced a host of manufacturing troubles as of late, landing lead companies like Ranbaxy and Wockhardt in hot water with regulators on both sides of the Atlantic. Now, some drugmakers--like Dr. Reddy's Laboratories--are wondering whether those could be reduced by taking human workers out of the equation. Story (sub. req.)